comparemela.com

Latest Breaking News On - Glenmark life sciences to nirma - Page 1 : comparemela.com

Share Market Highlights 13 March 2024: Sensex sheds 906 pts, Nifty slips below 22k amidst turmoil in small-, mid-cap segments

Share Market Highlights 13 March 2024: Sensex sheds 906 pts, Nifty slips below 22k amidst turmoil in small-, mid-cap segments
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United statesSaudi arabiaAndhra pradeshUnited kingdomWest bengalJammu and kashmirUnited arab emiratesAnil yadavAmit kumar singhVikas jainAuro pharmaJagdish kumar aroraAurobindo pharmaPrashanth tapseDeepak jasaniAdani wilmar

api: 4 insights to kick-start your day, featuring Glenmark finally sealing the deal

In Primeshots today: Glenmark sells stake in subsidiary; Good news for semiconductors; Alibabas logistics IPO; and Bank Niftys volatility.

Glenmark pharmaGlenmark life sciencesGlenmark life sciences to nirmaGlenmark pharmaceuticalsGlenmark lifeBank nifty

Glenmark Pharma, Glenmark Life shares in news on Nirma deal What analysts say

Glenmark Pharma, Glenmark Life: The fresh move, analysts said, may help Glenmark Pharma pare debt and increase its emphasis on branded or innovative products, they said.

Glenrmark pharmaGlenmark pharmaGlenmark life sciences to nirmaGlenmark pharmaceuticals ltd pharmaGlenmark pharmaceuticals ltdGlenmark life sciencesOswal securitiesInstitutional equitiesGlenmark lifeGlenmark life sciencesGlenmark pharma sharesLenmark life sharesGlenmark pharmaGlenmark life sciences

Glenmark Pharma shares falls 2% after subsidiary stake sale to Nirma

According to a regulatory filing, Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma to divest 75 percent stake in Glenmark Life Sciences for Rs 5,651.5 crore, at a price of Rs 615 per share.

Sekhmet pharmaventuresGlenmark pharmaGlen saldanhaMotilal oswalGlenmark lifesciencesGlenmark life sciences for rsGlenmark life sciencesGlenmark life sciences to nirmaGlenmark pharmaceuticalsGlenmark life

Glenmark Pharma to sell 75% stake in life sciences unit to Nirma for Rs5,651 crore

Glenmark Pharmaceuticals Ltd (GPL) has agreed to divest 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Limited at a price of Rs 615 per share, implying an equity valuation of Rs 7,535.4 crore.

Glenmark pharmaGlenmark life sciences to nirmaGlenmark pharmaceuticals ltdGlenmark life sciencesPharmaceuticals ltdNirma limitedMutual fund returnsAnk fixed depositsNvestor returnsOrtfolio allocation

vimarsana © 2020. All Rights Reserved.